FCE
Fiera Capital (Europe) Portfolio holdings
AUM $213M
1-Year Return
42.4%
This Quarter Return
-4.25%
1 Year Return
+42.4%
3 Year Return
+41.22%
5 Year Return
–
10 Year Return
–
AUM
$132M
AUM Growth
-$46.3M
(-26%)
Cap. Flow
-$36.8M
Cap. Flow
% of AUM
-27.85%
Top 10 Holdings %
Top 10 Hldgs %
80.05%
Holding
61
New
10
Increased
17
Reduced
23
Closed
8
Top Buys
| 1 |
Fomento Económico Mexicano
FMX
|
+$2.36M |
| 2 |
AVH
AVIANCA HOLDINGS S.A.
AVH
|
+$1.71M |
| 3 |
Johnson & Johnson
JNJ
|
+$306K |
| 4 |
CZZ
Cosan Limited
CZZ
|
+$260K |
| 5 |
Insulet
PODD
|
+$231K |
Top Sells
| 1 |
Banco Santander Chile
BSAC
|
+$12.3M |
| 2 |
MBT
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
|
+$9.81M |
| 3 |
Vale
VALE
|
+$4.66M |
| 4 |
Copa Holdings
CPA
|
+$2.45M |
| 5 |
Petrobras Class A
PBR.A
|
+$2.05M |
Sector Composition
| 1 | Consumer Staples | 28.96% |
| 2 | Financials | 22.33% |
| 3 | Communication Services | 16.83% |
| 4 | Materials | 9.65% |
| 5 | Energy | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$93.9B
| $198K | 0.15% |
3,822
+1,122
| +42% | +$58.1K |
|
|
OREX
27
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $182K | 0.14% |
+2,830
| New | +$182K |
|
28
Gilead Sciences
GILD
$139B
| $177K | 0.13% |
2,502
-501
| -17% | -$35.4K |
|
29
Viatris
VTRS
$11.2B
| $170K | 0.13% |
3,485
+2,034
| +140% | +$99.2K |
|
30
Medtronic
MDT
$121B
| $167K | 0.13% |
2,718
+1,077
| +66% | +$66.2K |
|
31
Thermo Fisher Scientific
TMO
$178B
| $155K | 0.12% |
+1,286
| New | +$155K |
|
|
MDVN
32
DELISTED
MEDIVATION, INC.
MDVN
| $148K | 0.11% |
4,588
+3,586
| +358% | +$116K |
|
33
Illumina
ILMN
$15.5B
| $142K | 0.11% |
979
| – | – |
|
34
Sanofi
SNY
$114B
| $142K | 0.11% |
2,700
| – | – |
|
35
Innoviva
INVA
$1.22B
| $140K | 0.11% |
5,401
+2,255
| +72% | +$58.5K |
|
36
Amgen
AMGN
$148B
| $131K | 0.1% |
1,065
-315
| -23% | -$38.7K |
|
|
FRX
37
DELISTED
FOREST LABORATORIES INC
FRX
| $117K | 0.09% |
1,269
+157
| +14% | +$14.5K |
|
|
SLXP
38
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $110K | 0.08% |
1,068
+698
| +189% | +$71.9K |
|
|
NSTG
39
DELISTED
NanoString Technologies, Inc.
NSTG
| $85K | 0.06% |
+4,081
| New | +$85K |
|
40
Becton Dickinson
BDX
$53.8B
| $82K | 0.06% |
+714
| New | +$82K |
|
41
Abbott
ABT
$234B
| $75K | 0.06% |
1,940
+267
| +16% | +$10.3K |
|
42
Biogen
BIIB
$21.2B
| $72K | 0.05% |
236
-200
| -46% | -$61K |
|
43
Regeneron Pharmaceuticals
REGN
$62.1B
| $70K | 0.05% |
233
-92
| -28% | -$27.6K |
|
|
NPSP
44
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $56K | 0.04% |
+1,876
| New | +$56K |
|
45
Arrowhead Research
ARWR
$4.03B
| $54K | 0.04% |
3,305
-33,860
| -91% | -$553K |
|
|
PCYC
46
DELISTED
PHARMACYCLICS INC
PCYC
| $52K | 0.04% |
+519
| New | +$52K |
|
|
CVD
47
DELISTED
COVANCE INC.
CVD
| $50K | 0.04% |
842
+467
| +125% | +$27.7K |
|
48
IQVIA
IQV
$31.7B
| $49K | 0.04% |
973
+227
| +30% | +$11.4K |
|
|
CELG
49
DELISTED
Celgene Corp
CELG
| $49K | 0.04% |
696
-430
| -38% | -$30.3K |
|
|
CBST
50
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $45K | 0.03% |
612
+135
| +28% | +$9.93K |
|